ERBB2 and neoplasm: On the other hand, ST8176AA1 but not trastuzumab induced significant acetylation of histones and alpha-tubulin in ErbB2+, but not in ErbB2- (data not shown), tumor cells of different origin (Figure 3B and Supplementary Figure S7).